PCSK9 and COVID-19: Thus, statin and PCSK9 inhibitor treatment for the lowering of LDL-C levels, when used together with a strong antithrombotic medication, may impair hemostasis and cause intracerebral bleeds which are mostly fatal in COVID-19 (51, 52).